Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunbathing and Bifidobacterium for Neonatal Hyperbilirubinemia
NCT06238349Phase 4Recruiting
- Sponsor
- Zhuhai Women's and Children's Hospital
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of bifidobacterium triple viable in neonatal hyperbilirubinemia, sponsored by Zhuhai Women's and Children's Hospital. Started Jan 2024; status: recruiting.
02
Drugs
bifidobacterium triple viable
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on NCT06238349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06238349.